Skip to content

AZ.PHARMABEL

Active Private limited company (pre-2019)founded 2013active for 13 yearsRichard Vandeveldestraat 57A, 1030 SchaerbeekKBO/BCE: BE 0508.863.780

Lifetime

12 annual accounts with figures on one time axis
peak of €246,451 in 2014
€69,439▼ 27.2%
lowest -€39,579 in 2017
€8,418▼ 81.9%
peak of €100,741 in 2025
€100,741▲ 9.1%
€378,823▲ 3.7%
peak of 1.5 FTE in 2014
-not published
Documentsfilings and deeds
18-02-202618 days late
2025financial year
Gross margin from €95,362 to €69,439Result from €46,416 to €8,418Investments €29,545

Key points

from the 2025 annual accounts

Debts

€378,823 79% of the balance sheet
Financial debts 25%Suppliers 67%Taxes and wages 6%Other 1%

€22,015 of the debts are secured on the company's own assets. In 2022 that was €389,131.

Investments

€29,544 5.2 times depreciation
2022202320242025

Green is investment, beige is depreciation.

Payment terms

104 days to suppliers
Suppliers
139 to 104
Customers
9 to 26

AZ.PHARMABEL pays its suppliers 35 days earlier than in 2024. Customers pay 17 days later.

2025 accounts filed 18 days after the deadline

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 4,111 companies had the same profile as AZ.PHARMABEL has now. Each dot stands for 11 companies, two years later.

97.9%
were still trading
0.9%
stopped another way
1.1%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 10 to 30%
  • a profit under 5% of the balance sheet
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 4,111 companies, not a prediction for AZ.PHARMABEL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

last known board
Manager, last mentioned in 2013
  • 186 sharesdeed of 15-01-2013
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0508863780
First establishment AZ PHARMABEL, Richard Vandeveldestraat 57A, Schaerbeek
Incorporation Founding capital of €18,600, 186 shares, €12,400 paid up · Founded by · appointed as manager · published on 15-01-2013 · Gazette deed
All 19 events

Comparable companies

same main activity, similar in size and age
Company
AZ.PHARMABEL Schaerbeek €479,564 €69,439 21.0% -
MEDICURO Stekene €457,159 €74,705 45.4% -
Smart Pharma Ixelles €483,477 €55,858 17.4% 1.1
PHARMACIE AVENUE DU ROI Forest €389,739 €82,300 69.7% -
Pharmacie GHUYSEN Blegny €446,214 €78,538 53.5% 0.2
Viventop Sambreville €460,629 €69,372 10.3% -
APOTHEEK OPLINTER Tienen €441,025 €81,205 55.3% 0.1

These companies have the same main activity as AZ.PHARMABEL: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €390,000 and €483,000, founded between 2010 and 2015.

Official details

Source: KBO
Status
Active since 03-01-2013Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730and 3 others
Establishment unit
2.216.172.5591030 Schaerbeek, since 06-02-2013
Financial year end
30 June
Peppol
Reachable since 30-11-2025
Company details

Annual accounts to 30-06-2025

€479,564▲ 4.8%
≈ 1 FTEestimated
Filing
Filed on 18-02-2026
Financials

Insights on AZ.PHARMABEL

AZ.PHARMABEL has existed since 2013. The gross margin fell from €246,451 in 2014 to €69,439 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about AZ.PHARMABEL

What is the company number of AZ.PHARMABEL?
The company number of AZ.PHARMABEL is 0508.863.780. The VAT number is the same number with BE in front: BE 0508.863.780.
Where is AZ.PHARMABEL based?
The registered office is at Richard Vandeveldestraat 57A, 1030 Schaerbeek.Company details
What does AZ.PHARMABEL do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of AZ.PHARMABEL?
AZ.PHARMABEL is a private limited company (pre-2019) (BVBA).
When was AZ.PHARMABEL founded?
AZ.PHARMABEL was founded on 03-01-2013.
Is AZ.PHARMABEL still active?
Yes, AZ.PHARMABEL is an active enterprise in the KBO register.
How many employees does AZ.PHARMABEL have?
AZ.PHARMABEL had an average of 1 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
What is the turnover of AZ.PHARMABEL?
The turnover of AZ.PHARMABEL was €966,662 in financial year 2025, according to the filed annual accounts.
Is AZ.PHARMABEL profitable?
In financial year 2025, AZ.PHARMABEL made a profit of €8,418.
Where can I find the annual accounts of AZ.PHARMABEL?
AZ.PHARMABEL filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of AZ.PHARMABEL due?
AZ.PHARMABEL must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.